These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

690 related items for PubMed ID: 19596346

  • 21. Vancomycin-resistant enterococci on a renal ward in an Ontario hospital.
    Lior L, Litt M, Hockin J, Kennedy C, Jolley BA, Garcia M, Gillis G, Humar A, Campbell I, Brunton J, Dedier H, Conly J.
    Can Commun Dis Rep; 1996 Aug 01; 22(15):125-8. PubMed ID: 8791860
    [No Abstract] [Full Text] [Related]

  • 22. Vancomycin-resistant enterococcal bacteremia: comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis.
    Chou YY, Lin TY, Lin JC, Wang NC, Peng MY, Chang FY.
    J Microbiol Immunol Infect; 2008 Apr 01; 41(2):124-9. PubMed ID: 18473099
    [Abstract] [Full Text] [Related]

  • 23. Bloodstream infections with vancomycin-resistant enterococci.
    Montecalvo MA, Shay DK, Patel P, Tacsa L, Maloney SA, Jarvis WR, Wormser GP.
    Arch Intern Med; 1996 Jul 08; 156(13):1458-62. PubMed ID: 8678715
    [Abstract] [Full Text] [Related]

  • 24. Vancomycin-resistant Enterococcus faecium osteomyelitis: successful treatment with quinupristin-dalfopristin.
    Summers M, Misenhimer GR, Antony SJ.
    South Med J; 2001 Mar 08; 94(3):353-5. PubMed ID: 11284529
    [Abstract] [Full Text] [Related]

  • 25. [Glycopeptide resistant enterococci. Occurrence, distribution, resistance transmission, significance].
    Klare I, Witte W.
    Wien Klin Wochenschr; 1997 May 09; 109(9):293-300. PubMed ID: 9265387
    [No Abstract] [Full Text] [Related]

  • 26. [Vancomycin (VCM) resistant enterococci (VRE)].
    Fujimoto S, Ike Y, Takahashi A, Yomoda S, Murakami M.
    Nihon Rinsho; 2003 Mar 09; 61 Suppl 3():182-9. PubMed ID: 12717969
    [No Abstract] [Full Text] [Related]

  • 27. Role of environmental contamination as a risk factor for acquisition of vancomycin-resistant enterococci in patients treated in a medical intensive care unit.
    Martínez JA, Ruthazer R, Hansjosten K, Barefoot L, Snydman DR.
    Arch Intern Med; 2003 Sep 08; 163(16):1905-12. PubMed ID: 12963563
    [Abstract] [Full Text] [Related]

  • 28. Costs and savings associated with infection control measures that reduced transmission of vancomycin-resistant enterococci in an endemic setting.
    Montecalvo MA, Jarvis WR, Uman J, Shay DK, Petrullo C, Horowitz HW, Wormser GP.
    Infect Control Hosp Epidemiol; 2001 Jul 08; 22(7):437-42. PubMed ID: 11583213
    [Abstract] [Full Text] [Related]

  • 29. [What is to be done with vancomycin-resistant enterococcal infections?].
    Bonten MJ, Mascini EM, Willems R, Timmer GJ, Gaillard CA, Vandenbroucke-Grauls CM.
    Ned Tijdschr Geneeskd; 2000 Dec 30; 144(53):2545-9. PubMed ID: 11191789
    [Abstract] [Full Text] [Related]

  • 30. Decolonisation for early control of an outbreak of vancomycin-resistant Enterococcus faecium in a geriatric rehabilitation care facility.
    Brossier F, Lefrançois S, Paute J, Gouot A, Golmard JL, Chaibi P, Pautas E, Berigaud S, Drieux L, Jarlier V, Aubry A.
    J Hosp Infect; 2010 Dec 30; 76(4):368-9. PubMed ID: 20850898
    [No Abstract] [Full Text] [Related]

  • 31. Control of an outbreak of vancomycin-resistant Enterococcus faecium in an oncology ward in South Africa: effective use of limited resources.
    McCarthy KM, Van Nierop W, Duse A, Von Gottberg A, Kassel M, Perovic O, Smego R.
    J Hosp Infect; 2000 Apr 30; 44(4):294-300. PubMed ID: 10772837
    [Abstract] [Full Text] [Related]

  • 32. Linezolid treatment for osteomyelitis due to vancomycin-resistant Enterococcus faecium.
    Till M, Wixson RL, Pertel PE.
    Clin Infect Dis; 2002 May 15; 34(10):1412-4. PubMed ID: 11981739
    [Abstract] [Full Text] [Related]

  • 33. Preventing the spread of vancomycin-resistant enterococci (VRE) in Canada.
    Division of Nosocomial and Occupationl Infectious Diseases, Bureau of Infectious Diseases, Laboratory Centre for Disease Control, Health Canada., VRE Working Group, Canadian Hospital Epidemiology Committee..
    Can Commun Dis Rep; 1997 Dec 15; 23 Suppl 8():i-iv, 1-16, i-iv, 1-19. PubMed ID: 11195274
    [No Abstract] [Full Text] [Related]

  • 34. Vancomycin-resistant enterococci (VRE): transmission and control.
    Tacconelli E, Cataldo MA.
    Int J Antimicrob Agents; 2008 Feb 15; 31(2):99-106. PubMed ID: 18164908
    [Abstract] [Full Text] [Related]

  • 35. Managing vancomycin-resistant enterococci. A winning team approach.
    Robinson K, Duff Z, Mercer J, Cran M, Gill-Morton P, Main S.
    Can Nurse; 1997 Nov 15; 93(10):36-9. PubMed ID: 9444145
    [Abstract] [Full Text] [Related]

  • 36. Detection of vancomycin-resistant enterococci colonization in a children's hospital.
    Christenson JC, Korgenski EK, Jenkins E, Daly JA.
    Am J Infect Control; 1998 Dec 15; 26(6):569-71. PubMed ID: 9836840
    [Abstract] [Full Text] [Related]

  • 37. Control of endemic vancomycin-resistant Enterococcus among inpatients at a university hospital.
    Calfee DP, Giannetta ET, Durbin LJ, Germanson TP, Farr BM.
    Clin Infect Dis; 2003 Aug 01; 37(3):326-32. PubMed ID: 12884155
    [Abstract] [Full Text] [Related]

  • 38. Effect of parenteral antibiotic administration on the establishment of colonization with vancomycin-resistant Enterococcus faecium in the mouse gastrointestinal tract.
    Donskey CJ, Hanrahan JA, Hutton RA, Rice LB.
    J Infect Dis; 2000 May 01; 181(5):1830-3. PubMed ID: 10823795
    [Abstract] [Full Text] [Related]

  • 39. Daptomycin nonsusceptible enterococci in hematologic malignancy and hematopoietic stem cell transplant patients: an emerging threat.
    Wudhikarn K, Gingrich RD, de Magalhaes Silverman M.
    Ann Hematol; 2013 Jan 01; 92(1):129-31. PubMed ID: 22869090
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 35.